Little Green Pharma’s (ASX: LGP) Expansion Plans
A presentation on Little Green Pharma's continual expansion.
Watch Now
Little Green Pharma was the first Australian company to achieve production of a locally-grown medicinal cannabis product for patient use. Established in 2016 as a privately-owned company in Perth, Western Australia, we have been supplying Australian patients with naturally-grown medicinal cannabis products since August 2018.
The company, together with its exclusive Manufacturing Partner and via its distribution arrangements, operates a vertically integrated medicinal cannabis business comprising cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products.
Little Green Pharma aims to take advantage of opportunities relating to the emerging medicinal cannabis industry in Australia and in certain international jurisdictions.
ASX Code
LGP
A presentation on Little Green Pharma's continual expansion.
Watch Now
Fleta Solomon - MD - Little Green Pharma is leading the Australian Medicinal Cannabis industry with Australia's first locally produced product available now for approved patients.
Watch Now
Presenter - Fleta Solomon - Managing Director - Little Green Pharma is leading the Australian Medicinal Cannabis industry with Australia's first locally produced product available now for approved patients.
Watch Now
Presenter - Paul Long - Chief Operating Officer - Little Green Pharma was the first Australian company to achieve the production of locally-grown medicinal cannabis products for patient use. The company operates a vertically integrated medicinal cannabis business comprising cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products.
Watch Now
Little Green Pharma (ASX: LGP) has received a manufacturing licence from the Therapeutic Goods Association (TGA), enabling it to manufacture medicinal cannabis in-house at its new Western Australia-based facility.
Watch Now
The uptake of medicinal cannabis products in Australia continues to boom, but most providers of the herbaceous material are not reaping the benefits because of oversupply, commoditised pricing and investor indifference.
Read More
Little Green Pharma (ASX:LGP) chief executive Paul Long attests to official data showing the rapid uptake of medical cannabis in Australia – albeit with some informal anecdotal observations.
Read More
Little Green Pharma (ASX:LGP) has announced that its Desert Flame high THC (20%) medicinal cannabis flower product has received Marketing Authorisation in Poland.
Read More
Known more as an Australian-focused medical cannabis minnow when it listed two years ago, Little Green Pharma now has access to more than half of the addressable EU market.
Read More
National private health insurer Health Insurance Fund of Australia (HIF) has formed a strategic partnership with Australian medicinal cannabis manufacturer Little Green Pharma (LGP) to support improved access and research into medicinal cannabis as a treatment option for Australian patients.
Read More
Little Green Pharma has become one of the few Australian cannabis companies with full approvals from both the TGA and the Office of Drug Control.
Read More
LGP granted ODC Medicinal Cannabis Cultivation and Production Permit for its expanded cultivation and manufacturing facility in Australia
Read More
Little Green Pharma was the first company to produce a home-grown medicinal cannabis product for patient use and it was also the first to export when it became legal to do so. Tim Boreham highlights why the company stands out as a genuine player above a canopy of chancers.
Read More